Use of flow cytometry for characterization of human cytomegalovirus vaccine particles (Q38782803)

6 September 2017

Use of flow cytometry for characterization of human cytomegalovirus vaccine particles (English)

1 reference

6 September 2017

0 references

1 reference

Josef Vlasak

1

1 reference

6 September 2017

Van M Hoang

2

1 reference

6 September 2017

Sianny Christanti

3

1 reference

6 September 2017

Richard Peluso

4

1 reference

6 September 2017

Fengsheng Li

5

1 reference

6 September 2017

Timothy D Culp

6

1 reference

6 September 2017

language of work or name

English

0 references

publication date

25 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

34

1 reference

6 September 2017

20

1 reference

6 September 2017

2321-2328

1 reference

Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.

6 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Vaccine prevention of maternal cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Human Cytomegalovirus: Purification of Enveloped Virions and Dense Bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Detection and discrimination of individual viruses by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Flow cytometer for measurement of the light scattering of viral and other submicroscopic particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Sorting of small infectious virus particles by flow virometry reveals distinct infectivity profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Circulating microparticles: challenges and perspectives of flow cytometric assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Overcoming limitations of microparticle measurement by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Single-step isolation of extracellular vesicles by size-exclusion chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Flow cytometric detection of viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Optimization of procedures for counting viruses by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Enumeration of bacteriophages using flow cytometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

Proteins associated with purified human cytomegalovirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.067

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2016.03.067

1 reference

6 September 2017

1 reference